Importantly, patients should never share their injection pens or devices with others, even if the needle is changed
It does not replace the official medication guide, patient information leaflet, counseling from your pharmacist, or medical advice from your prescriber
GLP-1 medications are a class of medicines called glucagon-like peptide-1 receptor agonists
GLP-1 RA cardiovascular outcome trials in patients with T2D reported a neutral impact of the drugs on HF hospitalisation
We haven't seen the ones that yet to be with semaglutide or other agents
Huynh C, Ryu J, Lee J, Inoki A, Inoki K (2023) Nutrient-sensing mTORC1 and AMPK pathways in chronic kidney diseases